Michele Holcomb - 18 Mar 2026 Form 3 Insider Report for COMPUGEN LTD (CGEN)

Reporting relationship: Director
Issuer ticker: CGEN
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 06:08:13 UTC
Prior SEC filing: 18 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Michele Holcomb

Key filing fact

Michele Holcomb filed Form 3 for COMPUGEN LTD (CGEN) on 18 Mar 2026.

Key facts

This page summarizes Michele Holcomb's Form 3 filing for COMPUGEN LTD (CGEN).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Mar 2026, 06:08.

Change

Previous filing in this sequence was filed on 18 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001694167 Primary reporting owner

Holcomb Michele

Relationship: Director
Address: C/O COMPUGEN LTD., 26 HAROKMIM STREET, HOLON, ISRAEL
Signature: /s/ Michele Holcomb
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CGEN holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 15,000
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CGEN holding Derivative

Share Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 20,000
Exercise price: $1.76
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock units ("RSUs") which vest 25% on April 1, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

Footnote F2

This option vests 25% on April 1, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.